Article
Gene expression analysis reveals functional pathways of glatiramer acetate activation
8 Mar 2013
Abstract excerpt
BACKGROUND: Glatiramer acetate (GA, Copaxone®), a mixture of polymers comprising four amino acids, is approved for treatment of relapsing-remitting multiple sclerosis and clinically isolated syndrome. GA mediates its activity by induction of GA-specific T cells that shift the T cell balance from a dominant proinflammatory phenotype (Th1/Th17) to an anti-inflammatory phenotype (Th2/Treg). OBJECTIVE: To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.